Table 3.
Adjusted HRs with 95% CIs for the risk of all-cause and cardiovascular mortality associated with statin use stratified by sex
Whole population (n=17 262) | Women (n=8981) | Men (n=8281) | |
All-cause mortality (nevent=1035) | |||
No statin (ref) | 1 | 1 | 1 |
Statin | 0.76 (0.71 to 0.82) | 0.66 (0.58 to 0.74) | 0.89 (0.81 to 0.96) |
Cardiovascular mortality (nevent=270) | |||
No statin (ref) | 1 | 1 | 1 |
Statin | 0.72 (0.61 to 0.83) | 0.55 (0.39 to 0.71) | 0.93 (0.77 to 1.08) |